Navigating Industry Needs for Retina Therapy Clinical Research Success

Healthcare > Clinical Trials12/11/2023 4:00 PM

Go to Registration Page


In this groundbreaking webinar, discover the latest in retina therapy programs and clinical research to enhance success in ophthalmic trials with insights from industry experts. With over 250 individual therapies in development to address these challenging-to-treat conditions including inherited retina diseases, diabetic retinopathy and macular degeneration, the innovation within this space is likely unsurpassed by any other. Excitingly, many of these include novel mechanisms of action or gene therapies that show potential for different therapeutic impacts from current therapies on the market, such as treating conditions where there are no therapies with approved indications or targeting earlier-stage disease interventions.


Rate This Webinar

community rating (0 votes): 
Rate or Review This Webinar




Ora is a leading full-service ophthalmic research organization that specializes in clinical and preclinical ophthalmic development. With over 40 years of experience, Ora has a proven track record of accelerating product development timelines and has helped its clients achieve more than 50 FDA approvals. They offer a wide range of services, including clinical trial management, preclinical and clinical research services, regulatory consulting, and patient and site solutions. Ora's team of experts combines their extensive knowledge and experience to guide and support clients throughout the entire product development process. With their expertise in therapeutic areas such as ocular surface and anterior segment, posterior segment, and ophthalmic devices, Ora is committed to advancing research and innovation in ophthalmology.